Related Experiment Video

Updated: Mar 31, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K

Correction: Synthesis and multifaceted exploration of dibenzoxepinones: in vitro antimicrobial and ct-DNA binding,

Shilpa Yadav1, Mansi1, Priyanshu2

  • 1University School of Basic & Applied Sciences, Guru Gobind Singh Indraprastha University Dwarka New Delhi-110078 India leenakhanna@ipu.ac.in.

RSC Advances
|March 30, 2026
PubMed

Abstract:

[This corrects the article DOI: 10.1039/D5RA01068C.].

More Related Videos

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
03:29

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

1.0K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Related Experiment Videos

Last Updated: Mar 31, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K
Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
03:29

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms

Published on: May 31, 2024

1.0K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

43
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
43
Antifungal Agents01:15

Antifungal Agents

42
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
42

Articles linked to this work by shared authors, journal, and citation graph.

ATG9 and ATG2 as lipid managers at the crossroads of autophagy and extracellular vesicle secretion.

Autophagy·2026

Self-Reconstructing, Conductive Bismuth Organic Framework Enables Effective Alloying and High-Capacity Potassium-Ion Anodes.

Small (Weinheim an der Bergstrasse, Germany)·2026

Ultrasound-assisted extraction via RSM, phytochemical profiling and evaluation of TPC, TFC, α-glucosidase inhibitory & antioxidant activity of Crotalaria willdenowiana DC. Extracts.

Preparative biochemistry & biotechnology·2026

Lipid-manager autophagy proteins ATG2 and ATG9 regulate extracellular vesicle secretion via amphisome biogenesis and cell lipidome modulation.

Nature communications·2026

Emerging Aluminum-Ion Capacitors and Lessons from Battery Chemistry.

Small (Weinheim an der Bergstrasse, Germany)·2026

Multifunctional Curcumin-Inspired 3,5-Diarylidene-4-Piperidones: Design, Synthesis, Biological Evaluation and Computational Mechanistic Studies.

Pharmaceuticals (Basel, Switzerland)·2026

Multi-component self-assembled trithiocyanurato-bridged manganese(i)- and rhenium(i)-based diverse shaped tri- and hexanuclear metallacages.

RSC advances·2026

Development of 7-hydroxy-4-methylcoumarin-cyanoacrylate hybrids with antiproliferative activity against breast cancer cells: from molecular design to in vivo validation.

RSC advances·2026

Organometallic complexes as donors and non-fullerene acceptors for organic solar cells: DFT-guided design, structure-property relationships, and future directions.

RSC advances·2026

A reversible indole-based colorimetric chemosensor for Cu2+: implications for smartphone-integrated sensing, logic gate experiments, environmental and biological applications.

RSC advances·2026

Elucidating the active site on PdPt nanocatalysts supported by MoS2-x for the hydrogen evolution reaction.

RSC advances·2026

Cobalt induced electronic and defect structure modulation in nickel iron layered double hydroxides for electrochemical, photo-electrochemical and photocatalytic water splitting.

RSC advances·2026

CSK-DDI: Compensating Structural Incompleteness with Knowledge Graph World Knowledge for Drug-Drug Interaction Modeling.

Bioinformatics (Oxford, England)·2026

Evaluation of capsid inhibitor resistance profiles and HIV-1 subtype distribution via near-full-length genome NGS in ART-naive HIV-1 patients in Guangxi, China.

The Journal of antimicrobial chemotherapy·2026

Antihypertensive drug-induced liver injury is rare, but strongly associated with HLA-B∗35:01.

Acta pharmaceutica Sinica. B·2026

Erratum: Author correction to "Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR" [Acta Pharm Sin B 12 (2022) 1339-1350].

Acta pharmaceutica Sinica. B·2026

Discovery of a potent covalent inhibitor for the treatment of sepsis targeting DNAJC9: Identification of a druggable target for inflammation.

Acta pharmaceutica Sinica. B·2026

Identification and characterization of a non-nucleotide RdRp allosteric inhibitor with pan-coronavirus protection.

Acta pharmaceutica Sinica. B·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us